S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
Clinical trial NCT00433446 · COMPLETED
Trial details
- NCT number
- NCT00433446
- Sponsor
- SWOG Cancer Research Network
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Primary completion
- 2009-05-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.